154 related articles for article (PubMed ID: 3514778)
1. Oxidative demethylation of lanosterol in cholesterol biosynthesis: accumulation of sterol intermediates.
Shafiee A; Trzaskos JM; Paik YK; Gaylor JL
J Lipid Res; 1986 Jan; 27(1):1-10. PubMed ID: 3514778
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P-450-dependent oxidation of lanosterol in cholesterol biosynthesis. Microsomal electron transport and C-32 demethylation.
Trzaskos JM; Bowen WD; Shafiee A; Fischer RT; Gaylor JL
J Biol Chem; 1984 Nov; 259(21):13402-12. PubMed ID: 6208195
[TBL] [Abstract][Full Text] [Related]
3. Effect of trans-1,4-bis(2-chlorobenzylaminomethyl) cyclohexane dihydrochloride and carbon monoxide on hepatic cholesterol biosynthesis from 4,4,-dimethyl sterols in vitro.
Gibbons GF; Mitropoulos KA
Biochim Biophys Acta; 1975 Feb; 380(2):270-81. PubMed ID: 1120146
[TBL] [Abstract][Full Text] [Related]
4. Lanosterol 14 alpha-demethylase (P45014DM): effects of P45014DM inhibitors on sterol biosynthesis downstream of lanosterol.
Tuck SF; Patel H; Safi E; Robinson CH
J Lipid Res; 1991 Jun; 32(6):893-902. PubMed ID: 1940622
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic studies of lanosterol C-32 demethylation. Conditions which promote oxysterol intermediate accumulation during the demethylation process.
Trzaskos JM; Fischer RT; Favata MF
J Biol Chem; 1986 Dec; 261(36):16937-42. PubMed ID: 3782148
[TBL] [Abstract][Full Text] [Related]
6. Lanosterol 14 alpha-methyl demethylase. Isolation and characterization of the third metabolically generated oxidative demethylation intermediate.
Fischer RT; Trzaskos JM; Magolda RL; Ko SS; Brosz CS; Larsen B
J Biol Chem; 1991 Apr; 266(10):6124-32. PubMed ID: 2007571
[TBL] [Abstract][Full Text] [Related]
7. Regulation of hepatic cholesterol biosynthesis. Effects of a cytochrome P-450 inhibitor on the formation and metabolism of oxygenated sterol products of lanosterol.
Iglesias J; Gibbons GF
Biochem J; 1989 Dec; 264(2):495-502. PubMed ID: 2604729
[TBL] [Abstract][Full Text] [Related]
8. The metabolic sequence by which some 4,4-dimethyl sterols are converted into cholesterol.
Gibbons GF
Biochem J; 1974 Oct; 144(1):59-68. PubMed ID: 4462576
[TBL] [Abstract][Full Text] [Related]
9. Studies on the 14 alpha-demethylation mechanism in cholesterol biosynthesis.
Galli-Kienle M; Anastasia M; Cighetti G; Galli G; Fiecchi A
Eur J Biochem; 1980 Sep; 110(1):93-105. PubMed ID: 7439165
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol biosynthesis from lanosterol: development of a novel assay method and characterization of rat liver microsomal lanosterol delta 24-reductase.
Bae SH; Paik YK
Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):609-16. PubMed ID: 9291139
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of 32-hydroxy-24,25-dihydrolanosterol by purified cytochrome P-45014DM from yeast. Evidence for contribution of the cytochrome to whole process of lanosterol 14 alpha-demethylation.
Aoyama Y; Yoshida Y; Sonoda Y; Sato Y
J Biol Chem; 1987 Jan; 262(3):1239-43. PubMed ID: 3543000
[TBL] [Abstract][Full Text] [Related]
12. Concerning the role of 24,25-dihydrolanosterol and lanostanol in sterol biosynthesis by cultured cells.
Nes WD; Norton RA; Parish EJ; Meenan A; Popják G
Steroids; 1989; 53(3-5):461-75. PubMed ID: 2799854
[TBL] [Abstract][Full Text] [Related]
13. Microsomal enzymes of cholesterol biosynthesis from lanosterol. Solubilization and purification of steroid 8-isomerase.
Paik YK; Billheimer JT; Magolda RL; Gaylor JL
J Biol Chem; 1986 May; 261(14):6470-7. PubMed ID: 2422166
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of sterol synthesis. Differential effects of 14 alpha-hydroxymethyl-5 alpha-cholest-7-ene-3 beta, 15 alpha-diol and 14 alpha-hydroxymethyl-5 alpha-cholest-6-ene-3 beta, 15 alpha-diol on sterol synthesis in cell-free homogenates of rat liver.
Miller LR; Pascal RA; Schroepfer GJ
J Biol Chem; 1981 Aug; 256(15):8085-91. PubMed ID: 7263642
[TBL] [Abstract][Full Text] [Related]
15. Identification of intermediates after inhibition of cholesterol synthesis by aminotriazole treatment in vivo.
Hashimoto F; Hayashi H
Biochim Biophys Acta; 1991 Oct; 1086(1):115-24. PubMed ID: 1954238
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 32-oxo-24,25-dihydrolanosterols by partially purified cytochrome P-450(14DM) from rat liver microsomes.
Sonoda Y; Sekigawa Y; Sato Y
Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2762-5. PubMed ID: 2611935
[TBL] [Abstract][Full Text] [Related]
17. Oxidative metabolism of cholesterol precursors: sensitivity to ketoconazole, an inhibitor of cytochrome P-450.
Iglesias J; Gibbons GF
Steroids; 1989; 53(3-5):311-28. PubMed ID: 2799848
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of cholesterol biosynthesis. Further studies of the metabolism of 5 alpha-cholest-8(14)-en-3 beta-ol-15-one in rat liver preparations.
Monger DJ; Schroepfer GJ
Chem Phys Lipids; 1988 May; 47(1):21-46. PubMed ID: 3396133
[TBL] [Abstract][Full Text] [Related]
19. Peroxisomal cholesterol synthesis in vivo: accumulation of 4-methyl intermediate sterols after aminotriazole inhibition of cholesterol synthesis.
Hashimoto F; Hayashi H
Biochim Biophys Acta; 1994 Aug; 1214(1):11-9. PubMed ID: 8068723
[TBL] [Abstract][Full Text] [Related]
20. Aberrant pathways in the late stages of cholesterol biosynthesis in the rat. Origin and metabolic fate of unsaturated sterols relevant to the Smith-Lemli-Opitz syndrome.
Ruan B; Tsai J; Wilson WK; Schroepfer GJ
J Lipid Res; 2000 Nov; 41(11):1772-82. PubMed ID: 11060346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
